163 related articles for article (PubMed ID: 21524565)
1. Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.
Oxman MN; Gershon AA; Poland GA
Vaccine; 2011 May; 29(20):3625-7. PubMed ID: 21524565
[No Abstract] [Full Text] [Related]
2. [Vaccination is worthwhile - also in advanced age].
MMW Fortschr Med; 2013 Jan; 155(1):26. PubMed ID: 23573713
[No Abstract] [Full Text] [Related]
3. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
Tseng HF; Smith N; Sy LS; Jacobsen SJ
Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
[TBL] [Abstract][Full Text] [Related]
4. Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination.
Brotherton AL; Shah R
R I Med J (2013); 2020 Aug; 103(6):34-37. PubMed ID: 32752563
[TBL] [Abstract][Full Text] [Related]
5. Practical points for applying herpes zoster vaccine recommendations.
Brogie JD; Rumph JH; Chaplin MD; Drake N; Hodge BK; Owens RE
Nurse Pract; 2019 Sep; 44(9):43-47. PubMed ID: 31436592
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H
Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212
[TBL] [Abstract][Full Text] [Related]
7. Real-World Evidence for Regulatory Decisions: Concomitant Administration of Zoster Vaccine Live and Pneumococcal Polysaccharide Vaccine.
Bruxvoort K; Sy LS; Luo Y; Tseng HF
Am J Epidemiol; 2018 Sep; 187(9):1856-1862. PubMed ID: 29659663
[TBL] [Abstract][Full Text] [Related]
8. Concomitant administration of pneumococcal-23 and zoster vaccines provides adequate herpes zoster coverage.
Wyman MJ; Stabi KL
Ann Pharmacother; 2013; 47(7-8):1064-8. PubMed ID: 23715069
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: a randomized study of a single dose vs. two different two-dose schedules.
Vesikari T; Hardt R; Rümke HC; Icardi G; Montero J; Thomas S; Sadorge C; Fiquet A
Hum Vaccin Immunother; 2013 Apr; 9(4):858-64. PubMed ID: 23319176
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
[TBL] [Abstract][Full Text] [Related]
11. Perspective of the U.S. Food and Drug Administration on concomitant administration of Zostavax and Pneumovax.
Baylor NW
Vaccine; 2011 Nov; 29(48):8771; author reply 8772. PubMed ID: 21864628
[No Abstract] [Full Text] [Related]
12. The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older.
Lehmann BA; Eilers R; Mollema L; Ferreira J; de Melker HE
BMC Geriatr; 2017 Jun; 17(1):122. PubMed ID: 28592229
[TBL] [Abstract][Full Text] [Related]
13. Assessing correlates of protection in vaccine trials.
Wittes J
J Infect Dis; 2014 Nov; 210(10):1523-5. PubMed ID: 24823622
[No Abstract] [Full Text] [Related]
14. Australia's national zoster vaccination program: Knowledge, attitudes and behaviour of general practitioners.
Rashid H; Dey A; Manocha R; Tashani M; Macartney K; Beard F
Commun Dis Intell (2018); 2020 Jul; 44():. PubMed ID: 32664832
[TBL] [Abstract][Full Text] [Related]
15. Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations.
; Husein N; Chetty A
Can J Diabetes; 2018 Apr; 42 Suppl 1():S142-S144. PubMed ID: 29650086
[No Abstract] [Full Text] [Related]
16. A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
Miller G; Schaefer H; Yoder S; Miller R; Winokur P; Kotloff K; Klassen D; Wierzbicki M; Amegashie C; Edwards K
Transpl Infect Dis; 2018 Jun; 20(3):e12874. PubMed ID: 29512282
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster virus redux.
Gelb LD
Herpes; 2009 Jan; 15(3):62-3. PubMed ID: 19306605
[TBL] [Abstract][Full Text] [Related]
19. Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination.
Elkin Z; Cohen EJ; Goldberg JD; Gillespie C; Li X; Jung J; Cohen M; Park L; Perskin MH
Cornea; 2013 Jul; 32(7):976-81. PubMed ID: 23449488
[TBL] [Abstract][Full Text] [Related]
20. What are the new vaccination recommendations for herpes zoster?
Mospan CM; Colvin N
JAAPA; 2018 Oct; 31(10):14-15. PubMed ID: 30252758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
